APOLIPOPROTEIN-E PHENOTYPING BY ISOELECTRIC-FOCUSING IN IMMOBILIZED PH GRADIENTS AND SILVER STAINING

被引:11
作者
CARTIER, R [1 ]
SASSOLAS, A [1 ]
机构
[1] NEUROCHIRURG PIERRE WERTHEIMER,F-69394 LYONS 03,FRANCE
关键词
D O I
10.1002/elps.1150130151
中图分类号
Q5 [生物化学];
学科分类号
071010 ; 081704 ;
摘要
A simple and high resolution procedure of apoprotein E (apo E) phenotyping by isoelectric focusing with immobilized pH gradients and silver staining is described. This method needs delipidated very low density lipoproteins (isolated from 1 mL of serum) but obviates immunoblotting as well as neuraminidase treatment in routine applications because the sialylated forms are clearly separated. Immunoblotting (with polyclonal and monoclonal anti-apo E antiserum), cysteamine and neuraminidase treatment, and pI markers allowed the localization of three main alleles, xi-2, xi-3, xi-4 and the detection of variants or rare alleles (6/450 determinations). The serum amyloid A (SAA) apolipoproteins (SAA1, SAA2) could be characterized unequivocally (especially with E3 and E4). Silver staining proved more sensitive than Coomassie Brilliant Blue and needs only 5-mu-g of protein in the sample. The results of 403 normo-or hyperlipidemic patients are shown. In the group of 191 normolipidemic patients (cholesterol < 6.40 mmol/L triglycerides < 2 mmol/L), the relative frequency of the xi-3 allele (0.83) is higher than in other reports on Caucasians (about 0.77) whereas the xi-4 allele is lower. As previously described, we find a high frequency of the 4/3 phenotype in hypercholesterolemia and 3/2 in hypertriglyceridemia. The high frequency of the E2/E2 phenotype, usually associated with hyperlipidemia, and variants in complex hypertriglyceridemia makes the apo E phenotyping necessary in many cases of dyslipidemias.
引用
收藏
页码:252 / 257
页数:6
相关论文
共 30 条
[1]  
ASSMANN G, 1984, CLIN CHEM, V30, P641
[2]   ISOELECTRIC-FOCUSING OF APOLIPOPROTEINS IN IMMOBILIZED PH GRADIENTS - IMPROVED DETERMINATION OF APOLIPOPROTEIN-E PHENOTYPES [J].
BAUMSTARK, MW ;
BERG, A ;
HALLE, M ;
KEUL, J .
ELECTROPHORESIS, 1988, 9 (09) :576-579
[3]   THE RECEPTOR MODEL FOR TRANSPORT OF CHOLESTEROL IN PLASMA [J].
BROWN, MS ;
GOLDSTEIN, JL .
ANNALS OF THE NEW YORK ACADEMY OF SCIENCES, 1985, 454 :178-182
[4]   APOLIPOPROTEIN-E POLYMORPHISM AND ATHEROSCLEROSIS [J].
DAVIGNON, J ;
GREGG, RE ;
SING, CF .
ARTERIOSCLEROSIS, 1988, 8 (01) :1-21
[5]  
EHNHOLM C, 1986, J LIPID RES, V27, P227
[6]   APOLIPOPROTEIN-E POLYMORPHISM AND HYPERLIPEMIA IN TYPE-II DIABETICS [J].
ETO, M ;
WATANABE, K ;
IWASHIMA, Y ;
MORIKAWA, A ;
OSHIMA, E ;
SEKIGUCHI, M ;
ISHII, K .
DIABETES, 1986, 35 (12) :1374-1382
[7]   A RAPID FLAT GEL ISOELECTRIC-FOCUSING METHOD FOR THE DETERMINATION OF APOLIPOPROTEIN-E PHENOTYPES AND ITS APPLICATION [J].
ETO, M ;
WATANABE, K ;
ISHII, K .
CLINICA CHIMICA ACTA, 1985, 149 (01) :21-28
[8]  
ETO M, 1990, ATHEROSCLEROSIS, V80, P49
[9]   DETECTION OF HUMAN-SERUM AMYLOID-A PROTEIN IN VERY LOW-DENSITY - AND HIGH-DENSITY LIPOPROTEINS OF PATIENTS AFTER ACUTE MYOCARDIAL-INFARCTION [J].
FEUSSNER, G ;
ZIEGLER, R .
ELECTROPHORESIS, 1989, 10 (11) :776-780
[10]   APOLIPOPROTEIN E3-LEIDEN - A NEW VARIANT OF HUMAN APOLIPOPROTEIN-E ASSOCIATED WITH FAMILIAL TYPE-3 HYPERLIPOPROTEINEMIA [J].
HAVEKES, L ;
DEWIT, E ;
LEUVEN, JG ;
KLASEN, E ;
UTERMANN, G ;
WEBER, W ;
BEISIEGEL, U .
HUMAN GENETICS, 1986, 73 (02) :157-163